Salivary lactoferrin as biomarker for Alzheimer's disease: Brain‐immunity interactions

OBJECTIVE: We aim to explain why salivary lactoferrin (Lf) levels are reduced in patients suffering mild cognitive impairment (MCI) and sporadic Alzheimer's disease (sAD).(1) We also will discuss if such Lf decrease could be due to a downregulation of the sAD associated systemic immunity. BACKG...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Alzheimers Dement
Main Authors: Bermejo‐Pareja, Félix, del Ser, Teodoro, Valentí, Meritxell, de la Fuente, Mónica, Bartolome, Fernando, Carro, Eva
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Theoretical Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7984071/
https://ncbi.nlm.nih.gov/pubmed/32543760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/alz.12107
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados